Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us

Jan Molenaar

Group leader
Prof. dr. Jan Molenaar leads a research group in the Princess Máxima Center, which focuses on precision medicine in pediatric cancer.
Phone +31 6 18051678
Email j.j.molenaar@prinsesmaximacentrum.nl

Publications

130 publications in total

  • Current treatment strategies for first relapse of high-risk neuroblastoma

    • mrt. 2026
    • Sveva, Castelli, et al
    • European Journal of Cancer

  • Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk

    • jan. 2026
    • Rixt S., Bruinsma, et al
    • Cancers

  • Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM

    • dec. 2025
    • Elke, Pfaff, et al
    • Acta Neuropathologica

  • Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma

    • nov. 2025
    • Ombretta, Melaiu, et al
    • Journal for ImmunoTherapy of Cancer

  • γδ T cells are the prime antitumoral T cells in pediatric neuroblastoma

    • nov. 2025
    • Suzanne M., Castenmiller, et al
    • Life science alliance
View all publications